市場調查報告書
商品編碼
1017198

褪黑激素的全球市場 (2021年∼2028年)

Global Melatonin Market - 2021-2028

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

由於對食品和飲料的需求增加以及失眠的流行率增加等因素,預計全球褪黑激素市場將繼續擴大。從種類上看,合成褪黑激素的佔有率最大,從應用上看,醫療行業的需求佔有率最大。就地區來看,北美國家是最大的市場。

本報告提供全球褪黑激素的市場相關分析,提供市場規模趨勢預測,及各類型·各用途·各地區的詳細趨勢,主要的推動及阻礙市場要素,主要企業的簡介等相關調查。

目錄

第1章 全球褪黑激素市場:分析方法·範圍

第2章 全球褪黑激素市場:市場定義和概要

第3章 全球褪黑激素市場:摘要整理

第4章 全球褪黑激素市場:市場動態

  • 對市場的影響要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球褪黑激素市場:產業分析

  • 波特的五力分析
  • PEST分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 全球褪黑激素市場:新型冠狀病毒感染疾病 (COVID-19)的分析

  • COVID-19對市場的影響分析
    • COVID-19前/過去的市場方案
    • COVID-19中/目前市場方案
    • COVID-19後/未來市場方案
  • COVID-19流行中的價格趨勢
  • 需求與供給的變動階段
  • 政府在COVID-19疫情下的市場相關措施
  • 各製造公司的策略展開情形
  • 結論

第7章 全球褪黑激素市場:各類型

  • 簡介
    • 市場規模的分析以及與前一年同期相比成長率 (YoY):各類型
    • 市場向心力指數:各類型
  • 合成褪黑激素
    • 簡介
    • 市場規模 (以金額為準,2018年∼2028年)·與前一年同期相比成長率 (YoY) (2020年∼2028年)
  • 天然褪黑激素

第8章 全球褪黑激素市場:各用途

  • 簡介
    • 市場規模的分析以及與前一年同期相比成長率 (YoY):各用途
    • 市場向心力指數:各用途
  • 醫療產業
  • 減肥營養補助食品
  • 建設業
  • 其他的用途

第9章 全球褪黑激素市場:各地區

  • 簡介
    • 市場規模 (以金額為準,2018年∼2028年)·與前一年同期相比成長率 (YoY) (2020年∼2028年):各地區
    • 市場向心力指數:各地區
  • 北美
    • 簡介
    • 域內市場固有趨勢
    • 市場規模·與前一年同期相比成長率 (YoY):各類型
    • 市場規模·與前一年同期相比成長率 (YoY):各用途
    • 市場規模·與前一年同期相比成長率 (YoY):各國
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第10章 全球褪黑激素市場:競爭情形

  • 主要趨勢與策略
  • 企業佔有率分析
  • 產品的互相比較
  • 值得注意的企業
  • 有顛覆性技術的企業
  • Start-Ups企業

第11章 全球褪黑激素市場:企業簡介

  • Natrol LLC
    • 企業概要
    • 產品的組合/概要
    • 近幾年趨勢
    • 主要的財務指標
  • Aspen Australia
  • Nature's Bounty
  • Pfizer
  • Biotics Research Corporation
  • Neurim Pharmaceuticals Ltd
  • Pulse Pharmaceuticals Pvt. Ltd
  • Flynn Pharma Ltd
  • Schiff Nutrition International Inc
  • BASF
  • Rixing Chemical CO., LTD
  • Hangzhou Cherry Pharmaceutical Technology
  • Hebei Lvyang Biotechnology Co., Ltd

第12章 關於DataM Intelligence

目錄
Product Code: DMHC3499

Market Overview

The global melatonin market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Melatonin is a hormone that helps in regulating the sleep-wake cycle and is produced naturally in the body. It is synthetically produced in a laboratory for treating short-term treatment of insomnia. It has antioxidant properties, expanding its applications across pharmaceuticals, food & beverages, and dietary supplements.

Market Dynamics

The melatonin market growth is driven by the increasing consumer spending on food products coupled with the growing demand for various food products, increasing stress levels have resulted in insomnia, delayed sleep, anxiety, thereby propelling the need for melatonin and growing demand for melatonin from the construction industry drive the market in the forecast period.

Growing consumption of the foods & beverages, is expected to drive the global melatonin market growth

The demand for melatonin supplements is increasing with the rising consumption of functional foods & beverages worldwide. The consumption of functional foods & beverages has increased with the growing awareness regarding their health and nutritional benefits. According to the National Center for Biotechnology Information (NCBI) survey, around 90% of American adults are aware of functional foods' benefits. This has resulted in boosting the sales of functional foods & beverages across the globe. According to the Institute of Food Technologists (IFT), total sales of functional foods were USD 247 billion worldwide in 2018.

The increasing consumer spending on food products, is expected to drive the global melatonin market growth

Increasing consumer spending on food products coupled with the growing demand for various food products is expected to propel the market growth of melatonin. According to the United States Department of Agriculture Economic Research Service, in 2019, food spending by U.S. consumers, businesses and government entities was valued at $1.77 trillion.

The increasing prevalence rate of insomnia, is expected to drive the growth in the forecast period

Melatonin supplements promote sleep and are safe for short-term use. Melatonin can treat delayed sleep phase and circadian rhythm sleep disorders in the blind and provide some insomnia relief. For instance, according to the NCBI National Center of Biotechnology Information and Sleep Foundation, around 70 million US citizens have a sleep disorder, with insomnia being the most common. 10% of people in the US have long-term (chronic) insomnia, and up to 30% of American adults have short-term insomnia, based on insomnia statistics.

Major side effects associated with melatonin is likely to hinder the market growth

Side effects of melatonin include short-lasting feelings of depression, mild tremor, mild anxiety, abdominal cramps, irritability, reduced alertness, confusion or disorientation, and abnormally low blood pressure (hypotension) may restrict the market growth.

COVID-19 Impact Analysis

Following the COVID-19 outbreak in December 2019, the disease has spread to over 100 countries globally, and the World Health Organization has declared it a public health emergency. According to the World Health Organization's report, the coronavirus (COVID-19) manifestation has resulted in more than 52.7 million infected individuals worldwide as of November 13, 2020.

The sudden outbreak of the novel coronavirus is expected to profound the growth of the melatonin market owing to an increase in the demand for sleep-related substitutes globally owing to increase stress and unhealthy lifestyle among the population worldwide. Moreover, it is estimated that the sales of sleeping remedies account for over US$ 1.04 billion in the United States in the year 2019-20.

Segment Analysis

The synthetic melatonin segment is expected to hold largest share in this market segment

Synthetic melatonin is made in a laboratory and doesn't contain animal products, making them vegan-friendly formulas. They're safer to use because you don't have to worry about possible biological contaminants. In bacteria, protists, fungi, and plants, melatonin is synthesized indirectly with tryptophan as an intermediate shikimate pathway product. In these cells, synthesis starts with D -erythrose 4-phosphate and phosphoenolpyruvate and photosynthetic cells with carbon dioxide.

The medical industry segment is expected to hold largest share in this market segment

Melatonin is a biogenic amine that is found in animals, plants, and microbes implicated in the regulation of mood, learning and memory, immune activity, dreaming, fertility, and reproduction. Additionally, melatonin is a hormone that regulates the sleep-wake cycle, primarily released by the pineal gland and used as a supplement for the short-term treatment of trouble sleeping, such as from jet lag or shift work. Melatonin contains antioxidant properties that reduce exercise-induced oxidative stress and provide a better environment for muscle protection and growth.

For instance, as per the American Psychiatric Association (APA) report, approximately one-third of adults have insomnia during their lifetime. It is manifested by ongoing problems in falling and staying asleep. Hence, due to the factors mentioned above, the application of melatonin from the medical industry is likely to dominate during the forecast period.

Geographical Analysis

North America region holds the largest market share of global melatonin market

The North American region is expected to dominate the market for melatonin during the forecast period. The rising demand for melatonin from the medical industry, with the growing insomnia problem in developed countries, like the United States and Canada, is expected to drive the demand for melatonin in this region. The largest producers of melatonin are located in the North American region. Some of the leading companies in melatonin production are Aspen Australia, Nature's Bounty, Pfizer, Natrol, LLC, an Aurobindo company, and Biotics Research Corporation. For instance, according to a US National Library of Science report, 40.2% of Canadian people have at least one symptom of insomnia.

Owing to the factors mentioned above, the market for melatonin in the North American region is projected to grow significantly during the study period.

Competitive Landscape

The global melatonin market is highly competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include Aspen Australia, Nature's Bounty, Pfizer, Natrol LLC, Biotics Research Corporation, Neurim Pharmaceuticals Ltd., Pulse Pharmaceuticals Pvt. Ltd., Flynn Pharma Ltd., Schiff Nutrition International Inc and BASF, Rixing Chemical CO., LTD, Hangzhou Cherry Pharmaceutical Technology, Hebei Lvyang Biotechnology Co., Ltd. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally.

Key Companies to Watch

Natrol LLC

Company Overview: A leading U.S. Vitamin, Mineral & Supplement manufacturer helping people around the world improve beauty, sleep, mood and brain health. Founded in 1980 by Elliott Balbert, Natrol begins as a cosmetics company. In 1982 Natrol entered the dietary supplements business with a nutritionally-based natural weight loss product named Natrol for "natural control." Natrol is considered a pioneer in formulating food into medicinal supplements for better health and wellness. In 2019 demonstrating that Natrol is one of the leading companies in its category in the US, they obtain the highest standard of nutraceutical certification with new USP accreditations for Melatonin and Biotin.

Product portfolio: The Company's portfolio comprised of include Vitamin, Mineral & Supplements.

Key Developments: In 2016, Natrol introduces Natrol 5mg Liquid Melatonin, a concentrated liquid, to help support sleep during the back-to-school transition.

Why Purchase the Report?

  • Visualize the composition of the melatonin market segmentation by type, application and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in melatonin market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of melatonin market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global melatonin market report would provide an access to an approx. 53 market data table, 42 figures and 200 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Melatonin Market - By Type

  • Natural Melatonin
  • Synthetic Melatonin

Global Melatonin Market - By Application

  • Medical Industry
  • Dietary Supplement
  • Construction Industry
  • Other Applications

Global Melatonin Market - By Region

  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America

Table of Contents

1. Global Melatonin Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Melatonin Market - Market Definition and Overview

3. Global Melatonin Market - Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Global Melatonin Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing consumption of the foods & beverages
      • 4.1.1.2. The increasing prevalence rate of insomnia
      • 4.1.1.3. The increasing consumer spending on food products
    • 4.1.2. Restraints:
      • 4.1.2.1. Side effects associated with melatonin
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Melatonin Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. PEST Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Global Melatonin Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Melatonin Market - By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Synthetic Melatonin*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Natural Melatonin

8. Global Melatonin Market - By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 8.1.2. Market Attractiveness Index, By Application Segment
  • 8.2. Medical Industry*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Dietary Supplement
  • 8.4. Construction Industry
  • 8.5. Other Applications

9. Global Melatonin Market - By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

10. Global Melatonin Market - Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking
  • 10.4. Key Companies to Watch
  • 10.5. Company with disruptive technology
  • 10.6. Start Up Companies

11. Global Melatonin Market- Company Profiles

  • 11.1. Natrol LLC*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Aspen Australia
  • 11.3. Nature's Bounty
  • 11.4. Pfizer
  • 11.5. Biotics Research Corporation
  • 11.6. Neurim Pharmaceuticals Ltd
  • 11.7. Pulse Pharmaceuticals Pvt. Ltd
  • 11.8. Flynn Pharma Ltd
  • 11.9. Schiff Nutrition International Inc
  • 11.10. BASF
  • 11.11. Rixing Chemical CO., LTD
  • 11.12. Hangzhou Cherry Pharmaceutical Technology
  • 11.13. Hebei Lvyang Biotechnology Co., Ltd

LIST NOT EXHAUSTIVE

12. Global Melatonin Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us